US$ 29.18
nct02637284 bpc-157 trial A human was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched BPC-157: The Body Protection Compound
Description
Zudem sind mgliche Langzeitfolgen kaum erforscht

Hair quality: Hair often becomes noticeably thicker and stronger

Ipamorelin, with its shorter half-life and cleaner cortisol/prolactin profile, is added to provide pulsatile GHRP-driven GH release layered on MK-677's sustained baseline
Medical Science Monitor Though clinical trials for humans remain limited, animal models and anecdotal evidence strongly suggest the potential of these peptides
